亚急性硬化性全脑炎可通过麻疹疫苗接种来预防。
Subacute sclerosing panencephalitis should be eliminated by measles vaccination.
机构信息
a Department of Pediatrics , Affiliated Hospital of Guizhou Medical University , Guiyang , China.
b Department of Ophthalmology , Affiliated Hospital of Guizhou Medical University , Guiyang , China.
出版信息
Hum Vaccin Immunother. 2017 Sep 2;13(9):2038-2040. doi: 10.1080/21645515.2017.1358582.
Abstract
1 patient with SSPE at 4 y. He had had measles and measles encephalitis at 7.5 months. In China, the first and the second measles immunizations are recommended at 8 months and at 18-24 months, respectively. We recommend above immunizations should be given separately at 6 months and at 12-15 months.
摘要
1 例 SSPE 患者，4 岁。7.5 个月时患麻疹并发生麻疹脑炎。中国建议分别于 8 个月和 18-24 个月龄时进行初免和复种麻疹疫苗。我们建议分别于 6 个月龄和 12-15 个月龄时进行上述免疫接种。
相似文献
1
Subacute sclerosing panencephalitis should be eliminated by measles vaccination.亚急性硬化性全脑炎可通过麻疹疫苗接种来预防。
Hum Vaccin Immunother. 2017 Sep 2;13(9):2038-2040. doi: 10.1080/21645515.2017.1358582.
2
Subacute Sclerosing Panencephalitis: The Foothold in Undervaccination.亚急性硬化性全脑炎：疫苗接种不足的症结所在
J Pediatr. 2016 Dec;179:259-262. doi: 10.1016/j.jpeds.2016.08.051. Epub 2016 Sep 12.
3
The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002.1990 - 2002年英格兰和威尔士亚急性硬化性全脑炎的流行病学
Arch Dis Child. 2004 Dec;89(12):1145-8. doi: 10.1136/adc.2003.038489.
4
Subacute sclerosing panencephalitis mortality, United States, 1979-2016: Vaccine-induced declines in SSPE deaths.亚急性硬化性全脑炎死亡率，美国，1979-2016 年：疫苗接种导致 SSPE 死亡人数下降。
Vaccine. 2018 Aug 23;36(35):5222-5225. doi: 10.1016/j.vaccine.2018.07.030. Epub 2018 Jul 26.
5
Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized.亚急性硬化性全脑炎：通过麻疹免疫预防的这种致命疾病病例比之前认为的更多。
J Infect Dis. 2005 Nov 15;192(10):1686-93. doi: 10.1086/497169. Epub 2005 Oct 12.
6
Pediatric Subacute Sclerosing Panencephalitis: A Narrative Review on Measles and the Future of Vaccination.小儿亚急性硬化性全脑炎：麻疹与未来疫苗接种的叙述性综述。
J Child Neurol. 2024 Mar;39(3-4):89-97. doi: 10.1177/08830738241238860. Epub 2024 Mar 13.
7
Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE).麻疹、麻疹疫苗接种与亚急性硬化性全脑炎（SSPE）风险
Neurology. 1983 Dec;33(12):1558-64.
8
[Subacute sclerosing panencephalitis (SSPE) in Poland 1984-1986. Stage III of epidemiologic studies].[1984 - 1986年波兰的亚急性硬化性全脑炎（SSPE）。流行病学研究的第三阶段]
Przegl Epidemiol. 1988;42(3):205-10.
9
Subacute sclerosing panencephalitis: a clinical dilemma.
J Trop Pediatr. 2000 Dec;46(6):380-1. doi: 10.1093/tropej/46.6.380.
10
Notes from the Field: Subacute Sclerosing Panencephalitis Death - Oregon, 2015.现场记录：亚急性硬化性全脑炎死亡病例 - 俄勒冈州，2015 年。
MMWR Morb Mortal Wkly Rep. 2016 Jan 15;65(1):10-1. doi: 10.15585/mmwr.mm6501a3.
本文引用的文献
1
Neuro-ophthalmology of subacute sclerosing panencephalitis: two cases and a review of the literature.亚急性硬化性全脑炎的神经眼科表现：两例病例报告及文献复习。
Curr Opin Ophthalmol. 2012 Nov;23(6):466-71. doi: 10.1097/ICU.0b013e328358b196.
2
Follow-up of infants given measles vaccine at 6 months of age: antibody and CMI responses to MMRII at 15 months of age and antibody levels at 27 months of age.
Vaccine. 2005 May 9;23(25):3247-55. doi: 10.1016/j.vaccine.2005.01.092.
3
Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.美国针对早期两剂麻疹疫苗接种方案的体液免疫和细胞介导免疫反应。
J Infect Dis. 2004 Jul 1;190(1):83-90. doi: 10.1086/421032. Epub 2004 May 26.
4
Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months.婴儿在6个月、9个月和12个月时对麻疹和腮腺炎疫苗接种的免疫反应。
J Infect Dis. 2001 Oct 1;184(7):817-26. doi: 10.1086/323346. Epub 2001 Aug 22.
5
Subacute sclerosing panencephalitis in Turkey: epidemiological features.
J Trop Pediatr. 1988 Dec;34(6):301-5. doi: 10.1093/tropej/34.6.301.
Zotero 插件